Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) traded down 3.6% during mid-day trading on Tuesday . The stock traded as low as $1.90 and last traded at $1.90. 38,020 shares traded hands during trading, a decline of 97% from the average session volume of 1,388,685 shares. The stock had previously closed at $1.97.
Hillstream BioPharma Stock Down 3.6 %
The stock’s 50 day moving average price is $2.05 and its 200-day moving average price is $2.29. The stock has a market capitalization of $33.45 million, a PE ratio of -2.64 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
See Also
- Five stocks we like better than Hillstream BioPharma
- There Are Different Types of Stock To Invest In
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- How is Compound Interest Calculated?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What is a Dividend King?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
